Guardian Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
9,417
-1,593
-14% -$41.7K 0.15% 59
2026
Q1
$309K Sell
11,010
-350
-3% -$9.32K 0.24% 55
2025
Q4
$283K Sell
11,360
-2,950
-21% -$74.4K 0.22% 56
2025
Q3
$365K Buy
14,310
+558
+4% +$13.8K 0.31% 53
2025
Q2
$333K Buy
13,752
+2,000
+17% +$46.6K 0.34% 49
2025
Q1
$294K Sell
11,752
-4,790
-29% -$125K 0.25% 55
2024
Q4
$436K Sell
16,542
-3,810
-19% -$103K 0.31% 53
2024
Q3
$589K Sell
20,352
-2,250
-10% -$65.6K 0.51% 45
2024
Q2
$632K Sell
22,602
-5,098
-18% -$140K 0.45% 47
2024
Q1
$769K Sell
27,700
-24,700
-47% -$685K 0.62% 43
2023
Q4
$1.51M Sell
52,400
-7,005
-12% -$212K 1.27% 24
2023
Q3
$1.97M Sell
59,405
-1,500
-2% -$53K 1.79% 19
2023
Q2
$2.23M Sell
60,905
-20,606
-25% -$802K 1.9% 19
2023
Q1
$2.95M Buy
81,511
+18,481
+29% +$798K 2.21% 17
2022
Q4
$3.23M Hold
63,030
3.05% 8
2022
Q3
$2.76M Sell
63,030
-11,400
-15% -$554K 2.8% 10
2022
Q2
$3.95M Buy
74,430
+50
+0.1% +$2.55K 3.44% 6
2022
Q1
$3.85M Sell
74,380
-2,050
-3% -$106K 2.99% 7
2021
Q4
$4.51M Buy
76,430
+400
+0.5% +$19.8K 3.14% 7
2021
Q3
$3.27M Sell
76,030
-5,635
-7% -$250K 2.41% 12
2021
Q2
$3.2M Buy
81,665
+154
+0.2% +$5.99K 2.19% 18
2021
Q1
$2.95M Buy
81,511
+6,500
+9% +$231K 2.1% 19
2020
Q4
$2.76M Sell
75,011
-2,575
-3% -$94.5K 2.09% 19
2020
Q3
$2.7M Buy
77,586
+527
+0.7% +$18.5K 2.35% 16
2020
Q2
$2.39M Buy
77,059
+1,845
+2% +$62.7K 2.17% 16
2020
Q1
$2.33M Buy
75,214
+9,011
+14% +$307K 2.39% 15
2019
Q4
$2.46M Buy
66,203
+3,373
+5% +$120K 1.96% 20
2019
Q3
$2.14M Buy
62,830
+270
+0.4% +$9.82K 1.9% 20
2019
Q2
$2.57M Buy
62,560
+61
+0.1% +$2.42K 2.24% 14
2019
Q1
$2.52M Sell
62,499
-5,375
-8% -$215K 2.18% 17
2018
Q4
$2.81M Sell
67,874
-738
-1% -$30.6K 2.6% 15
2018
Q3
$2.87M Buy
68,612
+1,860
+3% +$71.6K 2.52% 14
2018
Q2
$2.3M Buy
66,752
+4,559
+7% +$156K 2.2% 16
2018
Q1
$2.09M Hold
62,193
2.23% 19
2017
Q4
$2.14M Buy
62,193
+1,691
+3% +$57.7K 2.26% 18
2017
Q3
$2.05M Hold
60,502
2.26% 18
2017
Q2
$1.93M Sell
60,502
-5,280
-8% -$167K 2.13% 19
2017
Q1
$2.13M Sell
65,782
-2,098
-3% -$66.1K 2.32% 15
2016
Q4
$2.09M Buy
67,880
+6,412
+10% +$196K 2.41% 15
2016
Q3
$2.05M Hold
61,468
2.28% 14
2016
Q2
$2.05M Sell
61,468
-5,684
-8% -$181K 2.28% 14
2016
Q1
$1.89M Sell
67,152
-1,523
-2% -$43.5K 2.16% 16
2015
Q4
$2.1M Sell
68,675
-2,103
-3% -$66.2K 2.26% 15
2015
Q3
$2.14M Sell
70,778
-894
-1% -$28.7K 2.37% 15
2015
Q2
$2.29M Hold
71,672
2.56% 13
2015
Q1
$2.34M Sell
71,672
-2,108
-3% -$67K 2.6% 12
2014
Q4
$2.18M Hold
73,780
2.3% 13
2014
Q3
$2.25M Hold
73,780
2.6% 12
2014
Q2
$2.08M Hold
73,780
2.27% 14
2014
Q1
$2.25M Hold
73,780
2.6% 12
2013
Q4
$2.15M Buy
73,780
+5,270
+8% +$153K 2.38% 12
2013
Q3
$1.84M Hold
68,510
2.5% 12
2013
Q2
$1.82M Buy
+68,510
New +$1.89M 2.63% 12

Other funds holding PFE

Guardian Investment Management's PFE Position: Q2 2026 in Review

Guardian Investment Management reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $41.7K and leaving 9,417 shares worth $227K. The position accounts for 0.15% of the portfolio, ranked #59.

Guardian Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.51M in Q4 2021. 1,153 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Guardian Investment Management held 9,417 shares of Pfizer worth $227K as of Q2 2026.
  • Guardian Investment Management sold 1,593 Pfizer shares in Q2 2026, an estimated $41.7K.
  • Pfizer made up 0.15% of Guardian Investment Management's portfolio in Q2 2026, its #59 holding.
  • Guardian Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Guardian Investment Management's Pfizer position peaked at $4.51M in Q4 2021.
  • 1,153 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.